Toxicity and Treatment Completion of Neoadjuvant FOLFOXIRI and Chemoradiotherapy in Patients With High-Risk Locally Advanced Rectal Cancer: A Secondary Outcome Analysis of the MEND-IT Trial.

Saved in:
Bibliographic Details
Title: Toxicity and Treatment Completion of Neoadjuvant FOLFOXIRI and Chemoradiotherapy in Patients With High-Risk Locally Advanced Rectal Cancer: A Secondary Outcome Analysis of the MEND-IT Trial.
Authors: Banken, Evi1,2,3 (AUTHOR) evi.banken@catharinaziekenhuis.nl, van den Berg, Kim1,3 (AUTHOR), van Hellemond, Irene E.G.1 (AUTHOR), Peulen, Heike M.U.4 (AUTHOR), Nederend, Joost5 (AUTHOR), Steller, Ernst J.A.6 (AUTHOR), de Groot, Jan Willem B.7 (AUTHOR), Verhoef, Cornelis8 (AUTHOR), Aalbers, Arend G.J.9 (AUTHOR), Vincent, Jeroen10 (AUTHOR), Buffart, Tineke E.11 (AUTHOR), Werter, Inge M.12 (AUTHOR), Douma, Joeri A.J.13 (AUTHOR), Bloemen, Johanne G.2 (AUTHOR), Burger, Jacobus W.A.2,3 (AUTHOR)
Source: International Journal of Radiation Oncology, Biology, Physics. Jul2026, Vol. 125 Issue 4, p1008-1017. 10p.
Database: Academic Search Ultimate
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2025.12.052